Canada Markets open in 6 hrs 37 mins

Addex Therapeutics Ltd (ADDXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.99000.0000 (0.00%)
At close: 09:31AM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.80
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31.5600
52 Week Low 30.9900
50-Day Moving Average 30.9900
200-Day Moving Average 30.9900

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 526.37M
Implied Shares Outstanding 6N/A
Float 832.28M
% Held by Insiders 13.71%
% Held by Institutions 117.38%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CHF.

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)-1,302.76%

Management Effectiveness

Return on Assets (ttm)-78.64%
Return on Equity (ttm)-180.95%

Income Statement

Revenue (ttm)1.59M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)-82.60%
Gross Profit (ttm)-9.69M
EBITDA -20.84M
Net Income Avi to Common (ttm)-21.07M
Diluted EPS (ttm)-0.5280
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.81M
Total Cash Per Share (mrq)0.23
Total Debt (mrq)336.95k
Total Debt/Equity (mrq)4.91
Current Ratio (mrq)2.55
Book Value Per Share (mrq)0.54

Cash Flow Statement

Operating Cash Flow (ttm)-16.16M
Levered Free Cash Flow (ttm)-8.47M